Using Novel Imaging to More Safely Treat Neuroendocrine Tumors
Status:
Not yet recruiting
Trial end date:
2025-03-01
Target enrollment:
Participant gender:
Summary
The goal of this research is to determine if DetectnetTM PET/CT can be used to make Lutathera
therapy safer for patients with neuroendocrine cancer.
Participants will:
- Complete two phases involving 6 visits
- Undergo additional research PET/CT, and possibly SPECT/CT scans